Armata Pharmaceuticals, Inc.
ARMP
$5.57
-$0.42-7.01%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -386.68% | -281.34% | 73.90% | 113.10% | 82.41% |
| Total Depreciation and Amortization | 18.21% | 16.19% | 18.93% | 29.69% | 41.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 831.63% | 156.94% | -101.45% | -211.06% | -113.04% |
| Change in Net Operating Assets | 294.01% | -201.97% | 29.26% | 113.46% | -1,116.30% |
| Cash from Operations | 51.51% | 29.14% | 28.38% | 2.21% | 8.51% |
| Capital Expenditure | 28.82% | 89.09% | 60.40% | 103.21% | 90.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 28.82% | 89.09% | 60.40% | 103.22% | 90.32% |
| Total Debt Issued | -- | -- | -71.34% | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 47.54% | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 24,637.70% | -100.00% | -71.41% | 100.00% | -100.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 212.56% | 35.75% | -90.43% | 25.51% | -179.82% |